19 Jul Astellas Pharma
Posted at 18:27h
in
Richard Wilson,Head, Primary Focus Lead, Genetic Regulation
Oct. 6 | 3:30pm | FLW Ballroom F
Tokyo, Japan
(NASDAQ: ALPMY)
Astellas is a global life sciences company committed to turning innovative science into VALUE for patients. We provide transformative therapies in disease areas that include oncology, ophthalmology, urology, immunology and women’s health. Through our research and development programs, we are pioneering new healthcare solutions for diseases with high unmet medical need.